These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21405966)

  • 1. Something more is necessary: are genes and genetic diagnostic tests statutory subject matter for US patents?
    Cockbain J; Sterckx S
    Expert Rev Mol Diagn; 2011 Mar; 11(2):149-58. PubMed ID: 21405966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Bilski back to Benson: preemption, inventing around, and the case of genetic diagnostics.
    Dreyfuss R; Evans JP
    Stanford Law Rev; 2011 Jun; 63(6):1349-76. PubMed ID: 21774194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are natural products and medical diagnostic tests still eligible for patents in the USA?
    Cockbain J; Sterckx S
    Pharm Pat Anal; 2012 Sep; 1(4):365-70. PubMed ID: 24236874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care?
    Chandrasekharan S; McGuire AL; Van den Veyver IB
    Prenat Diagn; 2014 Oct; 34(10):921-6. PubMed ID: 24989832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene patents, patenting life and the impact of court rulings on US stem cell patents and research.
    Matthews KR; Cuchiara ML
    Regen Med; 2014 Mar; 9(2):191-200. PubMed ID: 24750060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The end of DNA patents in the United States?
    Webber P
    Expert Opin Ther Pat; 2013 Dec; 23(12):1525-7. PubMed ID: 24138004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.
    Abbot J
    J Law Med; 2006 Aug; 14(1):110-26. PubMed ID: 16937785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilski v. Kappos: the US Supreme Court broadens patent subject-matter eligibility.
    Simmons WJ
    Nat Biotechnol; 2010 Aug; 28(8):801-5. PubMed ID: 20697402
    [No Abstract]   [Full Text] [Related]  

  • 11. An overview of a recent court challenge to the protection of biomarkers as intellectual property.
    Hall SC; Tromp JM; Jortani SA
    Clin Chim Acta; 2011 May; 412(11-12):802-5. PubMed ID: 21315704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law.
    Huys I; Van Overwalle G; Matthijs G
    Eur J Hum Genet; 2011 Oct; 19(10):1104-7. PubMed ID: 21654725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patenting genetic diagnostic methods: NGS, GWAS, SNPs and patents.
    Lawson C
    J Law Med; 2015 Jun; 22(4):846-63. PubMed ID: 26349382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patenting DNA.
    Bobrow M; Thomas S
    Curr Opin Mol Ther; 2002 Dec; 4(6):542-7. PubMed ID: 12596355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACOG. Committee opinion: number 277, November 2002. Patients, medicine and the interests of patients: applying general principles to gene patenting.
    Comittee on Ethics, Comittee on Genetics, The American College of Obstetrician and Gynecologists
    Obstet Gynecol; 2002 Nov; 100(5 Pt 1):1051-6. PubMed ID: 12434779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene patenting--is the pendulum swinging back?
    Kesselheim AS; Mello MM
    N Engl J Med; 2010 May; 362(20):1855-8. PubMed ID: 20375396
    [No Abstract]   [Full Text] [Related]  

  • 17. DNA as patentable subject matter and a narrow framework for addressing the perceived problems caused by gene patents.
    Schilling SH
    Duke Law J; 2011 Dec; 61(3):731-73. PubMed ID: 22165443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.
    Offit K; Bradbury A; Storm C; Merz JF; Noonan KE; Spence R
    J Clin Oncol; 2013 Jul; 31(21):2743-8. PubMed ID: 23766521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prometheus: the Supreme Court redefines the patentability of diagnostic inventions.
    Kumamoto A; Schmid CL
    Recent Pat DNA Gene Seq; 2012 Dec; 6(3):193-6. PubMed ID: 22812581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.
    Aymé S; Matthijs G; Soini S;
    Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.